Baku 16° C
BioNTech, Pfizer studying new COVID variant
Health
- 26 November, 2021
- 13:30
BioNTech and Pfizer said that experts are studying a new variant of coronavirus discovered in South Africa, more information is expected in two weeks, Report informs.
“We expect more laboratory data in two weeks at the latest,” BioNTech spokesman said, according to Agence France-Presse.
The company stressed that the data will help to understand whether the variant of coronavirus B.1.1.529 could “require a vaccine adjustment” by Pfizer/BioNTech in the event that it spreads worldwide.
Author
Latest News
21:03
Photo
Statements regarding torture of Azerbaijanis held in captivity and as hostages by Armenia announced in court
Domestic policy21:00
Azerbaijani and NATO representatives meet at National Defense University
Military20:57
EU leaders agree to accelerate creation of unified defense system by 2030
Other countries20:36
NATO Secretary General to attend Coalition of the Willing meeting in UK
Other countries20:15
China state oil majors suspend Russian oil buys due to sanctions, sources say
Other countries20:02
Zelenskyy and Macron discuss defense cooperation and support for Ukraine
Other countries19:49
Zelenskyy: Ukraine should use Russian assets for weapons production
Other19:39
EU: Decision regarding use of Russian assets could be made by year-end
Other countries19:19